An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration

Neuropharmacology

Volumn 104, Issue , 2016, Pages 4-17

  Burnstock, Geoffrey ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ALS; Alzheimer's; ATP; MS; Parkinson's; Stem cells

Indexed keywords

2 CHLORO 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A2A RECEPTOR; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; PRELADENANT; PURINE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIMIDINE; SURAMIN; VIPADENANT; ADENOSINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT STEM CELL; ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYOTROPHIC LATERAL SCLEROSIS; BLUNT TRAUMA; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; HUMAN; HUNTINGTON CHOREA; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STAB WOUND; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; METABOLISM; NERVE CELL; NERVE REGENERATION; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; BRAIN; BRAIN ISCHEMIA; HUMANS; NERVE REGENERATION; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; NEURONS; PURINES; PYRIMIDINES; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y; SIGNAL TRANSDUCTION; STROKE;

EID: 84932171153     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.05.031     Document Type: Review

References (290)

1. M.P. Abbracchio ATP in brain function K.A. Jacobson, M.F. Jarvis, Purinergic Approaches in Experimental Therapeutics 1997 Wiley-Liss New York 383 404
2. M.P. Abbracchio, and G. Burnstock Purinergic signalling: pathophysiological roles Jpn. J. Pharmacol. 78 1998 113 145
3. M.P. Abbracchio, G. Burnstock, A. Verkhratsky, and H. Zimmermann Purinergic signalling in the nervous system: an overview Trends Neurosci. 32 2009 19 29
4. C. Agresti, M.E. Meomartini, S. Amadio, E. Ambrosini, B. Serafini, L. Franchini, C. Volonté, F. Aloisi, and S. Visentin Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development Glia 50 2005 132 144
5. C. Agresti, M.E. Meomartini, S. Amadio, E. Ambrosini, C. Volonté, F. Aloisi, and S. Visentin ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors Brain Res. Brain Res. Rev. 48 2005 157 165
6. J.L. Albasanz, S. Perez, M. Barrachina, I. Ferrer, and M. Martin Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease Brain Pathol. 18 2008 211 219
7. 12 receptor protein in cortical gray matter lesions in multiple sclerosis Cereb. Cortex 20 2010 1263 1273
8. S. Amadio, S. Apolloni, N. D'Ambrosi, and C. Volonté Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis J. Neurochem. 116 2011 796 805
9. M. Andries, P. Van Damme, W. Robberecht, and L. Van Den Bosch Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis Neurobiol. Dis. 25 2007 8 16
10. E. Angulo, V. Casado, J. Mallol, E.I. Canela, F. Vinals, I. Ferrer, C. Lluis, and R. Franco A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation Brain Pathol. 13 2003 440 451
11. 2A receptor antagonists in Parkinson's disease: still in the running Lancet Neurol. 13 2014 748 749
12. S. Apolloni, S. Amadio, C. Montilli, C. Volonté, and N. D'Ambrosi Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis Hum. Mol. Genet. 22 2013 4102 4116
13. S. Apolloni, S. Amadio, C. Parisi, A. Matteucci, R.L. Potenza, M. Armida, P. Popoli, N. D'Ambrosi, and C. Volonté Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis Dis. Model. Mech. 7 2014 1101 1109
14. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation Proc. Natl. Acad. Sci. U. S. A. 102 2005 19138 19143
15. 2 receptor activation: novel pathways for neuronal survival J. Neurosci. 26 2006 3798 3804
16. F. Azam, I.A. Ibn-Rajab, and A.A. Alruiad Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships Pharmazie 64 2009 771 795
17. 2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord J. Neurosci. 17 1997 5297 5304
18. R. Bartlett, L. Stokes, and R. Sluyter The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease Pharmacol. Rev. 66 2014 638 675
19. A. Bauer, K. Zilles, A. Matusch, C. Holzmann, O. Riess, and H.S. von Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation J. Neurochem. 94 2005 639 650
20. L.I. Benowitz, D.E. Goldberg, J.R. Madsen, D. Soni, and N. Irwin Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury Proc. Natl. Acad. Sci. U. S. A 96 1999 13486 13490
21. L.I. Benowitz, D.E. Goldberg, and N. Irwin A purine-sensitive mechanism regulates the molecular program for axon growth Restor. Neurol. Neurosci. 19 2001 41 49
22. C.S. Bindra, A.S. Jaggi, and N. Singh Role of P2X7 purinoceptors in neuroprotective mechanism of ischemic postconditioning in mice Mol. Cell. Biochem. 390 2014 161 173
23. I. Bjelobaba, I. Lavrnja, A. Parabucki, D. Stojkov, M. Stojiljkovic, S. Pekovic, and N. Nedeljkovic The cortical stab injury induces beading of fibers expressing ecto-nucleoside triphosphate diphosphohydrolase 3 Neuroscience 170 2010 107 116
24. I. Bjelobaba, A. Parabucki, I. Lavrnja, D. Stojkov, S. Dacic, S. Pekovic, L. Rakic, M. Stojiljkovic, and N. Nedeljkovic Dynamic changes in the expression pattern of ecto-5′-nucleotidase in the rat model of cortical stab injury J. Neurosci. Res. 89 2011 862 873
25. K.J. Black, J.M. Koller, M.C. Campbell, D.A. Gusnard, and S.I. Bandak Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease J. Neurosci. 30 2010 16284 16292
26. 3H]α,β-methylene ATP binding sites in rat brain and spinal cord Neuroreport 5 1994 1601 1604
27. G. Borsellino, M. Kleinewietfeld, M.D. Di, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M.L. Dell'Acqua, P.M. Rossini, L. Battistini, O. Rotzschke, and K. Falk Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression Blood 110 2007 1225 1232
28. H. Braak, and K. Del Tredici Assessing fetal nerve cell grafts in Parkinson's disease Nat. Med. 14 2008 483 485
29. R. Brambilla, G. Burnstock, A. Bonazzi, S. Ceruti, F. Cattabeni, and M.P. Abbracchio Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis Br. J. Pharmacol. 126 1999 563 567
30. N. Braun, Y. Zhu, J. Krieglstein, C. Culmsee, and H. Zimmermann Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat J. Neurosci. 18 1998 4891 4900
31. V.M. Brautigam, C. Frasier, M. Nikodemova, and J.J. Watters Purinergic receptor modulation of BV-2 microglial cell activity: potential involvement of p38 MAP kinase and CREB J. Neuroimmunol. 166 2005 113 125
32. K.M. Buller, S. Khanna, J.R. Sibbald, and T.A. Day Central noradrenergic neurons signal via ATP to elicit vasopressin responses to haemorrhage Neuroscience 73 1996 637 642
33. G. Burnstock Purinergic nerves Pharmacol. Rev. 24 1972 509 581
34. G. Burnstock Do some nerve cells release more than one transmitter? Neuroscience 1 1976 239 248
35. G. Burnstock A basis for distinguishing two types of purinergic receptor R.W. Straub, L. Bolis, Cell Membrane Receptors for Drugs and Hormones: a Multidisciplinary Approach 1978 Raven Press New York 107 118
36. G. Burnstock (Guest Editor). Purinergic neurotransmission Semin. Neurosci. 8 1996 171 257
37. G. Burnstock Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction J. Anat. 194 1999 335 342
38. G. Burnstock Purinergic receptors in the nervous system E.M. Schwiebert, Current Topics in Membranes Purinergic Receptors and Signalling vol. 54 2003 Academic Press San Diego 307 368
39. G. Burnstock Purine and pyrimidine receptors Cell. Mol. Life Sci. 64 2007 1471 1483
40. G. Burnstock Physiology and pathophysiology of purinergic neurotransmission b Physiol. Rev. 87 2007 659 797
41. G. Burnstock Purinergic signalling and disorders of the central nervous system Nat. Rev. Drug Discov. 7 2008 575 590
42. G. Burnstock The Erasmus Lecture 2012, Academia Europaea. The concept of cotransmission: focus on ATP as a cotransmitter and its significance in health and disease Eur. Rev. 22 2014 1 17
43. G. Burnstock Physiopathological roles of P2X receptors in the central nervous system Curr. Med. Chem. 22 2015 819 844
44. G. Burnstock, and G.E. Knight Cellular distribution and functions of P2 receptor subtypes in different systems Int. Rev. Cytol. 240 2004 31 304
45. G. Burnstock, and H. Ulrich Purinergic signalling in embryonic and stem cell development Cell. Mol. Life Sci. 68 2011 1369 1394
46. G. Burnstock, and A. Verkhratsky Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death Cell Death Dis. 1 2010 e9
47. G. Burnstock, and A. Verkhratsky Purinergic Signalling and the Nervous System 2012 Springer Heidelberg/Berlin
48. G. Burnstock, A. Verkhratsky, and B. Fredholm Adenosine and ATP receptors in the brain Curr. Top. Med. Chem. 11 2011 973 1011
49. E. Cakir, S. Baykal, S.C. Karahan, K. Kuzeyli, and H. Uydu Acute phase effects of ATP-MgCl2 on experimental spinal cord injury Neurosurg. Rev. 26 2003 67 70
50. 2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing J. Biol. Chem. 280 2005 18696 18702
51. 4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis J. Comp. Neurol. 506 2008 75 92
52. D.C. Cassada, C.G. Tribble, V.E. Laubach, B.N. Nguyen, J.M. Rieger, J. Linden, A.K. Kaza, S.M. Long, I.L. Kron, and J.A. Kern An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion J. Vasc. Surg. 34 2001 482 488
53. S. Ceruti, G. Villa, T. Genovese, E. Mazzon, R. Longhi, P. Rosa, P. Bramanti, S. Cuzzocrea, and M.P. Abbracchio The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury Brain 132 2009 2206 2218
54. S. Ceruti, F. Vigano, E. Boda, S. Ferrario, G. Magni, M. Boccazzi, P. Rosa, A. Buffo, and M.P. Abbracchio Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death Glia 59 2011 363 378
55. G.J. Chen, B.K. Harvey, H. Shen, J. Chou, A. Victor, and Y. Wang Activation of adenosine A3 receptors reduces ischemic brain injury in rodents J. Neurosci. Res. 84 2006 1848 1855
56. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice J. Neurosci. 19 1999 9192 9200
57. 2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation Prog. Neurobiol. 83 2007 310 331
58. -/- mice: evidence for loss of apoptotic activity in lymphocytes J. Immunol. 176 2006 3115 3126
59. Y. Chen, H. Wu, S. Wang, H. Koito, J. Li, F. Ye, J. Hoang, S.S. Escobar, A. Gow, H.A. Arnett, B.D. Trapp, N.J. Karandikar, J. Hsieh, and Q.R. Lu The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination Nat. Neurosci. 12 2009 1398 1406
60. 2A adenosine receptor protect neurons derived from induced pluripotent stem cells of patients with Huntington's disease J. Neurochem. 130 2014 15
61. A.M. Choo, W.J. Miller, Y.C. Chen, P. Nibley, T.P. Patel, C. Goletiani, B. Morrison III, M.K. Kutzing, B.L. Firestein, J.Y. Sul, P.G. Haydon, and D.F. Meaney Antagonism of purinergic signalling improves recovery from traumatic brain injury Brain 136 2013 65 80
62. 2 receptors activate neuroprotective mechanisms in astrocytic cells J. Neurochem. 91 2004 119 132
63. L.J. Christjanson, P.J. Middlemiss, and M.P. Rathbone Stimulation of astrocyte proliferation by purine and pyrimidine nucleotides and nucleosides Glia 7 1993 176 182
64. F. Ciruela, M. Gómez-Soler, D. Guidolin, D.O. Borroto-Escuela, L.F. Agnati, K. Fuxe, and V. Fernández-Dueñas Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain Biochim. Biophys. Acta 1808 2011 1245 1255
65. K.N. Corps, T.L. Roth, and D.B. McGavern Inflammation and neuroprotection in traumatic brain injury JAMA Neurol. 72 2015 355 362
66. O. Coskuner, and I.V. Murray Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro J. Alzheimers. Dis. 41 2014 561 574
67. M.L. Cotrina, J.H. Lin, J.C. Lopez-Garcia, C.C. Naus, and M. Nedergaard ATP-mediated glia signaling J. Neurosci. 20 2000 2835 2844
68. R.A. Cunha, and J.A. Ribeiro ATP as a presynaptic modulator Life Sci. 68 2000 119 137
69. N. D'Ambrosi, P. Finocchi, S. Apolloni, M. Cozzolino, A. Ferri, V. Padovano, G. Pietrini, M.T. Carrì, and C. Volonté The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis J. Immunol. 183 2009 4648 4656
70. M. Dallas, H.E. Boycott, L. Atkinson, A. Miller, J.P. Boyle, H.A. Pearson, and C. Peers Hypoxia suppresses glutamate transport in astrocytes J. Neurosci. 27 2007 3946 3955
71. D. Davalos, J. Grutzendler, G. Yang, J.V. Kim, Y. Zuo, S. Jung, D.R. Littman, M.L. Dustin, and W.B. Gan ATP mediates rapid microglial response to local brain injury in vivo Nat. Neurosci. 8 2005 752 758
72. C. Delarasse, R. Auger, P. Gonnord, B. Fontaine, and J.M. Kanellopoulos The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein J. Biol. Chem. 286 2011 2596 2606
73. J. Delic, and H. Zimmermann Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells Purinergic Signal 6 2010 417 428
74. M. Díaz-Hernández, M. Diez-Zaera, J. Sanchez-Nogueiro, R. Gomez-Villafuertes, J.M. Canals, J. Alberch, M.T. Miras-Portugal, and J.J. Lucas Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration FASEB J. 23 2009 1893 1906
75. M. Domercq, A. Perez-Samartin, D. Aparicio, E. Alberdi, O. Pampliega, and C. Matute P2X7 receptors mediate ischemic damage to oligodendrocytes Glia 58 2010 730 740
76. T.V. Dunwiddie The physiological role of adenosine in the central nervous system Int. Rev. Neurobiol. 27 1985 63 139
77. F.A. Edwards, A.J. Gibb, and D. Colquhoun ATP receptor-mediated synaptic currents in the central nervous system Nature 359 1992 144 147
78. H.K. Eltzschig, M.V. Sitkovsky, and S.C. Robson Purinergic signaling during inflammation N. Engl. J. Med. 367 2012 2322 2333
79. L. Erb, C. Cao, D. Ajit, and G.A. Weisman P2Y receptors in Alzheimer's disease Biol. Cell. 107 2015 1 21
80. R.F. Fern, C. Matute, and P.K. Stys White matter injury: Ischemic and nonischemic Glia 62 2014 1780 1789
81. B.L. Fiebich, S. Akter, and R.S. Akundi The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain Front. Cell. Neurosci. 8 2014 260
82. D. Fields, and G. Burnstock Purinergic signaling in neuron-glial interactions Nat. Neurosci. Rev. 7 2006 423 436
83. R.D. Fields, and B. Stevens-Graham New insights into neuron-glia communication Science 298 2002 556 562
84. 2 purinergic receptors in precerebellar nuclei Neuroscience 115 2002 425 434
85. H. Franke, J. Grosche, H. Schadlich, U. Krugel, C. Allgaier, and P. Illes P2X receptor expression on astrocytes in the nucleus accumbens of rats Neuroscience 108 2001 421 429
86. H. Franke, A. Gunther, J. Grosche, R. Schmidt, S. Rossner, R. Reinhardt, H. Faber-Zuschratter, D. Schneider, and P. Illes P2X7 receptor expression after ischemia in the cerebral cortex of rats J. Neuropathol. Exp. Neurol. 63 2004 686 699
87. H. Franke, U. Krugel, J. Grosche, C. Heine, W. Hartig, C. Allgaier, and P. Illes P2Y receptor expression on astrocytes in the nucleus accumbens of rats Neuroscience 127 2004 431 441
88. H. Franke, and P. Illes Involvement of P2 receptors in the growth and survival of neurons in the CNS Pharmacol. Ther. 109 2006 297 324
89. H. Franke, U. Krügel, and P. Illes P2 receptors and neuronal injury Pflugers Arch. 452 2006 622 644
90. H. Franke, B. Grummich, W. Härtig, J. Grosche, R. Regenthal, R.H. Edwards, P. Illes, and U. Krügel Changes in purinergic signaling after cerebral injury - involvement of glutamatergic mechanisms? Int. J. Dev. Neurosci. 24 2006 123 132
91. H. Franke, C. Schepper, P. Illes, and U. Krugel Involvement of P2X and P2Y receptors in microglial activation in vivo Purinergic. Signal. 3 2007 435 445
92. H. Franke Role of G protein-coupled receptors (GPCRs) for purines and pyrimidines in mediating degeneration and regeneration under neuroinflammatory processes Purinergic Signal 7 2011 1 5
93. H. Franke, C. Parravicini, D. Lecca, E.R. Zanier, C. Heine, K. Bremicker, M. Fumagalli, P. Rosa, L. Longhi, N. Stocchetti, M.G. De Simoni, M. Weber, and M.P. Abbracchio Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury Purinergic Signal 9 2013 451 462
94. N. Fujiwara, H. Higashi, K. Shimoji, and M. Yoshimura Effects of hypoxia on rat hippocampal neurones in vitro J. Physiol. 384 1987 131 151
95. M. Fumagalli, S. Daniele, D. Lecca, P.R. Lee, C. Parravicini, R.D. Fields, P. Rosa, F. Antonucci, C. Verderio, M.L. Trincavelli, P. Bramanti, C. Martini, and M.P. Abbracchio Phenotypic changes, signaling pathway and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation J. Biol. Chem. 286 2011 10593 10604
96. M. Gandelman, H. Peluffo, J.S. Beckman, P. Cassina, and L. Barbeito Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis J. Neuroinflammation. 7 2010 33
97. P.J. Gebicke-Haerter, F. Christoffel, J. Timmer, H. Northoff, M. Berger, and D. van Calker Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation Neurochem. Int. 29 1996 37 42
98. C. Giaume, F. Kirchhoff, C. Matute, A. Reichenbach, and A. Verkhratsky Glia: the fulcrum of brain diseases Cell. Death. Differ. 14 2007 1324 1335
99. A.J. Gibb, and F.C. Halliday Fast purinergic transmission in the central nervous system Semin. Neurosci. 8 1996 225 232
100. T. Glaser, R.R. Resende, and H. Ulrich Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation Cell. Commun. Signal 11 2013 12
101. C.V. Gomes, M.P. Kaster, A.R. Tomé, P.M. Agostinho, and R.A. Cunha Adenosine receptors and brain diseases: neuroprotection and neurodegeneration Biochim. Biophys. Acta 1808 2011 1380 1399
102. A.V. Gourine, E. Llaudet, N. Dale, and K.M. Spyer Release of ATP in the ventral medulla during hypoxia in rats: role in hypoxic ventilatory response J. Neurosci. 25 2005 1211 1218
103. A.V. Gourine, V. Kasymov, N. Marina, F. Tang, M.F. Figueiredo, S. Lane, A.G. Teschemacher, K.M. Spyer, K. Deisseroth, and S. Kasparov Astrocytes control breathing through pH-dependent release of ATP Science 329 2010 571 575
104. T. Grygorowicz, D. Sulejczak, and L. Struzynska Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits Acta Neurobiol. Exp. (Wars.) 71 2011 65 73
105. S. Guarnieri, G. Fanò, M.P. Rathbone, and M.A. Mariggiò Cooperation in signal transduction of extracellular guanosine 5' triphosphate and nerve growth factor in neuronal differentiation of PC12 cells Neuroscience 128 2004 697 712
106. + macrophages in rat CNS during experimental autoimmune encephalomyelitis Neuroscience 134 2005 199 205
107. 5 receptors in the mouse central nervous system Neuroscience 156 2008 673 692
108. 2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease Neurobiol. Dis. 67 2014 191 202
109. J.W. Gysbers, S. Guarnieri, M.A. Mariggiò, T. Pietrangelo, G. Fanò, and M.P. Rathbone Extracellular guanosine 5' triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium Neuroscience 96 2000 817 824
110. 4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 69 2010 176 187
111. V.H. Höpker, M.J. Saffrey, and G. Burnstock Neurite outgrowth of striatal neurons in vitro: involvement of purines in the growth promoting effect of myenteric plexus explants Int. J. Dev. Neurosci. 14 1996 439 451
112. Z. Hracskó, M. Baranyi, C. Csölle, F. Gölöncser, E. Madarász, A. Kittel, and B. Sperlágh Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease Mol. Neurodegener. 6 2011 28
113. N. Huang, D. Wang, and L.A. Heppel Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors Proc. Natl. Acad. Sci. U. S. A. 86 1989 7904 7908
114. C. Iadecola, and J. Anrather The immunology of stroke: from mechanisms to translation Nat. Med. 17 2011 796 808
115. M. Idzko, D. Ferrari, and H.K. Eltzschig Nucleotide signalling during inflammation Nature 509 2014 310 317
116. P. Illes, and H. Zimmermann Nucleotides and their receptors in the nervous system Prog. Brain Res. 120 1999 1 432
117. P. Illes, A. Verkhratsky, G. Burnstock, and H. Franke P2X receptors and their role in astroglia in the central and peripheral nervous system Neuroscientist 18 2012 422 438
118. K. Inoue, S. Koizumi, and S. Ueno Implication of ATP receptors in brain functions Prog. Neurobiol. 50 1996 483 492
119. K. Inoue ATP receptors for the protection of hippocampal functions Jpn. J. Pharmacol. 78 1998 405 410
120. T. Ishibashi, K.A. Dakin, B. Stevens, P.R. Lee, S.V. Kozlov, C.L. Stewart, and R.D. Fields Astrocytes promote myelination in response to electrical impulses Neuron 49 2006 823 832
121. K.L. Jansen, R.L. Faull, M. Dragunow, and B.L. Synek Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors-an autoradiographic study Neuroscience 39 1990 613 627
122. 2A antagonists, and Parkinson's disease Park. Relat. Disord. 15 2009 406 413
123. Y.H. Jo, and L.W. Role Coordinate release of ATP and GABA at in vitro synapses of lateral hypothalamic neurons J. Neurosci. 22 2002 4794 4804
124. D. Jun, and K. Kim ATP-mediated Necrotic Volume Increase (NVI) in Substantia Nigra Pars Compacta Dopaminergic Neuron 2004 Society for Neuroscience Washington, DC 18 Abstr, 222
125. E.S. Jung, K. An, H.S. Hong, J.H. Kim, and I. Mook-Jung Astrocyte-originated ATP protects Aβ(1-42)-induced impairment of synaptic plasticity J. Neurosci. 32 2012 3081 3087
126. J. Jung, H.W. Jo, H. Kwon, and N.Y. Jeong ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury Biomed. Res. Int. 2014 2014 936891
127. 2 receptor subunit of the ATP-gated ion channels in the rat central nervous system J. Comp. Neurol. 407 1999 11 32
128. 2 purinergic receptors in facial motoneurons after nerve lesions in rodents and correlation with motoneuron degeneration Neurobiol. Dis. 25 2007 121 133
129. F. Kato, M. Kawamura, E. Shigetomi, J. Tanaka, and K. Inoue ATP- and adenosine-mediated signaling in the central nervous system: synaptic purinoceptors: the stage for ATP to play its "dual-role" J. Pharmacol. Sci. 94 2004 107 111
130. H. Kawasaki, T. Morooka, S. Shimohama, J. Kimura, T. Hirano, Y. Gotoh, and E. Nishida Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells J. Biol. Chem. 272 1997 18518 18521
131. B.S. Khakh Molecular physiology of P2X receptors and ATP signalling at synapses Nat. Rev. Neurosci. 2 2001 165 174
132. A. Kharlamov, S.C. Jones, and D.K. Kim Suramin reduces infarct volume in a model of focal brain ischemia in rats Exp. Brain Res. 147 2002 353 359
133. 3 -sensitive internal stores in mammalian oligodendrocytes J. Physiol. 483 1995 41 57
134. K. Kogure, and O.F. Alonso A pictorial representation of endogenous brain ATP by a bioluminescent method Brain Res. 154 1978 273 284
135. K. Krnjevic Early effects of hypoxia on brain cell function Croat. Med. J. 40 1999 375 380
136. U. Krügel, H. Kittner, H. Franke, and P. Illes Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo Synapse 47 2003 134 142
137. F. Kukulski, J. Sevigny, and M. Komoszynski Comparative hydrolysis of extracellular adenine nucleotides and adenosine in synaptic membranes from porcine brain cortex, hippocampus, cerebellum and medulla oblongata Brain Res. 1030 2004 49 56
138. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J. Neurochem. 79 2001 463 484
139. E.R. Lazarowski, J.I. Sesma, L. Seminario-Vidal, and S.M. Kreda Molecular mechanisms of purine and pyrimidine nucleotide release Adv. Pharmacol. 61 2011 221 261
140. A. Lämmer, A. Gunther, A. Beck, U. Krugel, H. Kittner, D. Schneider, P. Illes, and H. Franke Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats Eur. J. Neurosci. 23 2006 2824 2828
141. A.B. Lämmer, A. Beck, B. Grummich, A. Förschler, T. Krügel, T. Kahn, D. Schneider, P. Illes, H. Franke, and U. Krügel The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo PLoS One 6 2011 e19983
142. R. Le Feuvre, D. Brough, and N. Rothwell Extracellular ATP and P2X7 receptors in neurodegeneration Eur. J. Pharmacol. 447 2002 261 269
143. D. Lecca, M.L. Trincavelli, P. Gelosa, L. Sironi, P. Ciana, M. Fumagalli, G. Villa, C. Verderio, C. Grumelli, U. Guerrini, E. Tremoli, P. Rosa, S. Cuboni, C. Martini, A. Buffo, M. Cimino, and M.P. Abbracchio The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair PLoS. One 3 2008 e3579
144. H.G. Lee, S.M. Won, B.J. Gwag, and Y.B. Lee Microglial P2X receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease Exp. Mol. Med. 43 2011 7 14
145. 2 nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells FEBS Lett. 585 2011 2255 2262
146. J.H. Lin, T. Takano, G. Arcuino, X. Wang, F. Hu, Z. Darzynkiewicz, M. Nunes, S.A. Goldman, and M. Nedergaard Purinergic signaling regulates neural progenitor cell expansion and neurogenesis Dev. Biol. 302 2007 356 366
147. Y. Lin, A. Desbois, S. Jiang, and S.T. Hou P2 receptor antagonist PPADS confers neuroprotection against glutamate/NMDA toxicity Neurosci. Lett. 377 2005 97 100
148. 3 receptors in rat sensory neurons Neuroreport 9 1998 2245 2250
149. 1 receptors in the rat cerebellum Cell. Tissue Res. 294 1998 253 260
150. T.A. Lusardi Adenosine neuromodulation and traumatic brain injury Curr. Neuropharmacol. 7 2009 228 237
151. P. Majumder, C.A. Trujillo, C.G. Lopes, R.R. Resende, K.N. Gomes, K.K. Yuahasi, L.R. Britto, and H. Ulrich New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders Purinergic Signal. 3 2007 317 331
152. 7 receptor antagonist A-438079 J. Neural Transm. 117 2010 681 687
153. G. Martino, and S. Pluchino The therapeutic potential of neural stem cells Nat. Rev. Neurosci. 7 2006 395 406
154. S.A. Masino, and T.V. Dunwiddie Role of purines and pyrimidines in the central nervous system M.P. Abbracchio, M. Williams, Handbook of Experimental Pharmacology. Purinergic and Pyrimidinergic Signalling I - Molecular, Nervous and Urinogenitary System Function 2001 Springer-Verlag Berlin 251 288
155. I. Matsuoka, and S. Ohkubo ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases J. Pharmacol. Sci. 94 2004 95 99
156. 7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis J. Neurosci. 27 2007 9525 9533
157. C. Matute, and F. Cavaliere Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders Semin. Cell. Dev. Biol. 22 2011 252 259
158. 7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus J. Neuropathol. Exp. Neurol. 65 2006 1090 1097
159. A. Melani, D. Turchi, M.G. Vannucchi, S. Cipriani, M. Gianfriddo, and F. Pedata ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia Neurochem. Int. 47 2005 442 448
160. A. Melani, S. Amadio, M. Gianfriddo, M.G. Vannucchi, C. Volonté, G. Bernardi, F. Pedata, and G. Sancesario P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat J. Cereb. Blood Flow. Metab. 26 2006 974 982
161. W. Même, P. Ezan, L. Venance, J. Glowinski, and C. Giaume ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 beta treatment in cultured astrocytes Neuroscience 126 2004 95 104
162. N. Messemer, C. Kunert, P. Illes, and P. Rubini Co-expression of functional P2X4 and P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone Open Neurosci. J. 7 2013 1 4
163. N. Messemer, C. Kunert, M. Grohmann, H. Sobottka, K. Nieber, H. Zimmermann, H. Franke, W. Nörenberg, I. Straub, M. Schaefer, T. Riedel, P. Illes, and P. Rubini P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone Neuropharmacology 73 2013 122 137
164. S. Mievis, D. Blum, and C. Ledent Worsening of Huntington disease phenotype in CB1 receptor knockout mice Neurobiol. Dis. 43 2011 524 529
165. M.T. Miras-Portugal, P. Marìn-García, L.M. Carrasquera, E.G. Delicado, M. Díaz-Hernández, R. Gómez-Villafuertes, J. Gualix, D. León, M. León-Otegui, F. Ortega, R. Pérez-Sen, E. Salas, and J. Sánchez-Nogueiro Physiological role of extracellular nucleotides at the central nervous system: signalling through P2X and P2Y receptors An. R. Acad. Nac. Farm. 73 2007 1127 1157
166. S.K. Mishra, N. Braun, V. Shukla, M. Füllgrabe, C. Schomerus, H.W. Korf, C. Gachet, Y. Ikehara, J. Sévigny, S.C. Robson, and H. Zimmermann Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation Development 133 2006 675 684
167. J. Mojsilovic-Petrovic, G.B. Jeong, A. Crocker, A. Arneja, S. David, D.S. Russell, and R.G. Kalb Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors J. Neurosci. 26 2006 9250 9263
168. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats Neuroreport 9 1998 3955 3959
169. 1 purinergic receptor in the human brain: striking neuronal localisation J. Comp. Neurol. 421 2000 374 384
170. 1 purinergic receptor in neurons and glial cells of the central nervous system Brain Res. Mol. Brain Res. 78 2000 50 58
171. A.C. Morandini, L.E. Savio, and R. Coutinho-Silva The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases Biomed. J. 37 2014 169 177
172. M. Morciano, S. Ortinau, and H. Zimmermann Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons Neurochem. Int. 45 2004 95 101
173. M. Morelli, A.R. Carta, A. Kachroo, and M.A. Schwarzschild Pathophysiological roles for purines: adenosine, caffeine and urate Prog. Brain Res. 183 2010 183 208
174. 13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery Biochim. Biophys. Acta 1843 2014 1886 1898
175. M. Mori, C. Heuss, B.H. Gahwiler, and U. Gerber Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures J. Physiol. 535 2001 115 123
176. 7 receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells Brain Pathol. 22 2012 295 306
177. 7 receptor expression and function in human astrocytes Glia 49 2005 245 258
178. J.T. Neary, S.R. Whittemore, Q. Zhu, and M.D. Norenberg Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP J. Neurochem. 63 1994 490 494
179. J.T. Neary, M.P. Rathbone, F. Cattabeni, M.P. Abbracchio, and G. Burnstock Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells Trends Neurosci. 19 1996 13 18
180. J.T. Neary, Y. Kang, K.A. Willoughby, and E.F. Ellis Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors J. Neurosci. 23 2003 2348 2356
181. J.T. Neary, Y. Kang, M. Tran, and J. Feld Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors J. Neurotrauma 22 2005 491 500
182. J.T. Neary, and Y. Kang Signaling from P2 nucleotide receptors to protein kinase cascades induced by CNS injury: implications for reactive gliosis and neurodegeneration Mol. Neurobiol. 31 2005 95 103
183. J.T. Neary, and Y. Kang P2 purinergic receptors signal to glycogen synthase kinase-3β in astrocytes J. Neurosci. Res. 84 2006 515 524
184. J.T. Neary, Y. Kang, Y.F. Shi, M.D. Tran, and I.B. Wanner P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions Novartis. Found. Symp. 276 2006 131 143
185. J.T. Neary, and H. Zimmermann Trophic functions of nucleotides in the central nervous system Trends Neurosci. 32 2009 189 198
186. N. Nedeljkovic, I. Bjelobaba, S. Subasic, I. Lavrnja, S. Pekovic, D. Stojkov, A. Vjestica, L. Rakic, and M. Stojiljkovic Up-regulation of ectonucleotidase activity after cortical stab injury in rats Cell. Biol. Int. 30 2006 541 546
187. K. Nieber, J. Sevcik, and P. Illes Hypoxic changes in rat locus coeruleus neurons in vitro J. Physiol. 486 1995 33 46
188. K. Nieber, W. Poelchen, and P. Illes Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat Br. J. Pharmacol. 122 1997 423 430
189. K. Nieber, D. Eschke, and A. Brand Brain hypoxia: effects of ATP and adenosine Prog. Brain Res. 120 1999 287 297
190. R.A. North, and A. Verkhratsky Purinergic transmission in the central nervous system Pflugers Arch. 452 2006 479 485
191. T. Ogata, M. Chuai, T. Morino, H. Yamamoto, Y. Nakamura, and P. Schubert Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors Brain Res. 981 2003 174 183
192. B.K. Ormerod, T.D. Palmer, and M.A. Caldwell Neurodegeneration and cell replacement Philos. Trans. R. Soc. Lond B Biol. Sci. 363 2008 153 170
193. Y. Pankratov, U. Lalo, E. Castro, M.T. Miras-Portugal, and O. Krishtal ATP receptor-mediated component of the excitatory synaptic transmission in the hippocampus Prog. Brain Res. 120 1999 237 249
194. Y. Pankratov, U. Lalo, O. Krishtal, and A. Verkhratsky Ionotropic P2X purinoreceptors mediate synaptic transmission in rat pyramidal neurones of layer II/III of somato-sensory cortex J. Physiol. 542 2002 529 536
195. Y. Pankratov, U. Lalo, O.A. Krishtal, and A. Verkhratsky P2X receptors and synaptic plasticity Neuroscience 158 2009 137 148
196. C. Parisi, I. Arisi, N. D'Ambrosi, A.E. Storti, R. Brandi, M. D'Onofrio, and C. Volonté Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation Cell. Death Dis. 4 2013 e959
197. V. Parpura, and R. Zorec Gliotransmission: exocytotic release from astrocytes Brain Res. Rev. 63 2010 83 92
198. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease J. Biol. Chem. 278 2003 13309 13317
199. F. Pedata, M. Gianfriddo, D. Turchi, and A. Melani The protective effect of adenosine A2A receptor antagonism in cerebral ischemia Neurol. Res. 27 2005 169 174
200. F. Pedata, A. Melani, A.M. Pugliese, E. Coppi, S. Cipriani, and C. Traini The role of ATP and adenosine in the brain under normoxic and ischemic conditions Purinergic. Signal. 3 2007 299 310
201. S. Pekovic, S. Subasic, N. Nedeljkovic, I. Bjelobaba, R. Filipovic, I. Milenkovic, I. Lavrnja, D. Stojkov, S. Jovanovic, L. Rakic, and M. Stojiljkovic Molecular basic of brain injury and repair S. Ruzdijic, L. Rakic, Neurobiological Studies - from Genes to Behaviour 2006 Research Signpost Kerala, India 143 165
202. W. Peng, M.L. Cotrina, X. Han, H. Yu, L. Bekar, L. Blum, T. Takano, G.F. Tian, S.A. Goldman, and M. Nedergaard Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury Proc. Natl. Acad. Sci. U. S. A. 106 2009 12489 12493
203. S. Perez-Lloret, and M. Merello Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant Expert. Opin. Pharmacother. 15 2014 1097 1107
204. 2 nucleotide receptor-mediated responses in brain cells Mol. Neurobiol. 41 2010 356 366
205. J.W. Phillis, and P.H. Wu The role of adenosine and its nucleotides in central synaptic transmission Prog. Neurobiol. 16 1981 187 239
206. V.C. Pimentel, M.B. Moretto, M.C. Oliveira, D. Zanini, A.M. Sebastiao, and M.R. Schetinger Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult Mol. Cell. Biochem. 403 2015 169 177
207. 2A receptor antagonists for Parkinson's disease Expert. Opin. Investig. Drugs 18 2009 1619 1631
208. W. Poelchen, D. Sieler, K. Wirkner, and P. Illes Co-transmitter function of ATP in central catecholaminergic neurons of the rat Neuroscience 102 2001 593 602
209. 2A recerptor stimulation enhances striatal extracellular glutamate levels in rats Eur. J. Pharmacol. 287 1995 215 217
210. 2A receptors Neurology 61 2003 S69 S71
211. 2A receptors in Huntington's disease Prog. Neurobiol. 81 2007 331 348
212. 2A receptors as potentially "druggable" targets in Huntington's disease Curr. Pharm. Des. 14 2008 1500 1511
213. P. Potter, and T.D. White Release of adenosine 5'-triphosphate from synaptosomes from different regions of rat brain Neuroscience 5 1980 1351 1356
214. V. Ralevic, and G. Burnstock Receptors for purines and pyrimidines Pharmacol. Rev. 50 1998 413 492
215. M.P. Rathbone, P.J. Middlemiss, J.W. Gysbers, C. Andrew, M.A. Herman, J.K. Reed, R. Ciccarelli, P. Di Iorio, and F. Caciagli Trophic effects of purines in neurons and glial cells Prog. Neurobiol. 59 1999 663 690
216. 2A analogue reduces long-term neurologic injury after blunt spinal trauma J. Surg. Res. 121 2004 130 134
217. J.A. Ribeiro Fine tuning neuromodulation by adenosine and neuroprotection An. R. Acad. Nac. Farm. 74 2008 387 408
218. J.A. Ribeiro, A.M. Sebastião, and A. de Mendonça Adenosine receptors in the nervous system: pathophysiological implications Prog. Neurobiol. 68 2003 377 392
219. S.J. Robertson, S.J. Ennion, R.J. Evans, and F.A. Edwards Synaptic P2X receptors Curr. Opin. Neurobiol. 11 2001 378 386
220. 4 receptors in the rat hippocampus J. Neurosci. 25 2005 6286 6295
221. 2 receptor subunit mediating ventilatory responses to hypoxia: knockout mouse studies J. Neurosci. 23 2003 11315 11321
222. J.K. Ryu, H.B. Choi, K. Hatori, R.L. Heisel, S.L. Pelech, J.G. McLarnon, and S.U. Kim Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase J. Neurosci. Res. 72 2003 352 362
223. J.K. Ryu, and J.G. McLarnon Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease Neuroreport 19 2008
224. 7 receptor expression J. Immunol. 182 2009 4378 4385
225. K. Schäfer, M.J. Saffrey, and G. Burnstock Trophic actions of 2-chloroadenosine and bFGF on cultured myenteric neurones Neuroreport 6 1995 937 941
226. S.C. Schock, D. Leblanc, A.M. Hakim, and C.S. Thompson ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in vitro Biochem. Biophys. Res. Commun. 368 2008 138 144
227. A.M. Sebastião, and J.A. Ribeiro Adenosine receptors and the central nervous system Handb. Exp. Pharmacol. 2009 471 534
228. 2A receptor antagonists for the treatment of Parkinson's disease Curr. Opin. Drug Discov. Develop. 13 2010 466 480
229. A.J. Sharp, P.E. Polak, V. Simonini, S.X. Lin, J.C. Richardson, E.R. Bongarzone, and D.L. Feinstein P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis J. Neuroinflammation. 5 2008 33
230. C.B. Shields, Y.P. Zhang, S. Chen, Y. Han, L.B.E. Shields, D.A. Burke, and R. Haskins Treatment of Spinal Cord Injury via Topical Perfusion with an ATP Solution 2004 Society for Neuroscience Washington, DC 2004 Abstract Viewer/Itinerary Planner; Program no. 418. 8
231. C.C. Shih, Y. Weng, A. Mamelak, T. LeBon, M.C. Hu, and S.J. Forman Identification of a candidate human neurohematopoietic stem-cell population Blood 98 2001 2412 2422
232. S.D. Skaper The brain as a target for inflammatory processes and neuroprotective strategies Ann. N. Y. Acad. Sci. 1122 2007 23 34
233. S.D. Skaper Ion channels on microglia: therapeutic targets for neuroprotection CNS Neurol. Disord. Drug Targets 10 2011 44 56
234. S.H. Snyder Adenosine as a neuromodulator Annu. Rev. Neurosci. 8 1985 103 124
235. R.M. Spanevello, C.M. Mazzanti, R. Kaizer, R. Zanin, D. Cargnelutti, L. Hannel, M. Correa, A. Mazzanti, R. Festugatto, D. Graca, M.R. Schetinger, and V.M. Morsch Apyrase and 5'-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon-β Neurochem. Res. 31 2006 455 462
236. B. Sperlágh, and P. Illes P2X7 receptor: an emerging target in central nervous system diseases Trends Pharmacol. Sci. 35 2014 537 547
237. 2-adrenoceptors Neuroscience 82 1998 511 520
238. B. Sperlágh, G. Zsilla, M. Baranyi, P. Illes, and E.S. Vizi Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus Neuroscience 149 2007 99 111
239. T.W. Stone Adenosine, neurodegeneration and neuroprotection Neurol. Res. 27 2005 161 168
240. T.W. Stone, S. Ceruti, and M.P. Abbracchio Adenosine receptors and neurological disease: neuroprotection and neurodegeneration Handb. Exp. Pharmacol. 2009 535 587
241. Z. Sun, L. Hu, Y. Wen, K. Chen, Z. Sun, H. Yue, and C. Zhang Adenosine triphosphate promotes locomotor recovery after spinal cord injury by activating mammalian target of rapamycin pathway in rats Neural Regen. Res. 8 2013 101 110
242. S. Suyama, T. Sunabori, H. Kanki, K. Sawamoto, C. Gachet, S. Koizumi, and H. Okano Purinergic signaling promotes proliferation of adult mouse subventricular zone cells J. Neurosci. 32 2012 9238 9247
243. 7 receptor-activated microglia J. Neurosci. 24 2004 1 7
244. T. Takenouchi, K. Sekiyama, A. Sekigawa, M. Fujita, M. Waragai, S. Sugama, Y. Iwamaru, H. Kitani, and M. Hashimoto P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases Arch. Immunol. Ther. Exp. (Warsz.) 58 2010 91 96
245. 2A receptor signaling in a mouse model of Huntington disease Neurobiol. Dis. 23 2006 44 53
246. E.M.M. Tew, P.N. Anderson, and G. Burnstock Implantation of the myenteric plexus into the corpus striatum of adult rats: survival of the neurones and glia and interactions with host brain Restor. Neurol. Neurosci. 4 1992 311 321
247. K. Tokui, M. Sakanaka, and S. Kimura Progressive reorganization of the myenteric plexus during one year following reanastomosis of the ileum of the guinea pig Cell. Tissue Res. 277 1994 259 272
248. C. Traini, F. Pedata, S. Cipriani, T. Mello, A. Galli, M.G. Giovannini, F. Cerbai, R. Volpini, G. Cristalli, and A.M. Pugliese P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro Eur. J. Neurosci. 33 2011 2203 2215
249. M.D. Tran P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes Neurosci. Lett. 492 2011 155 159
250. M.D. Tran, and J.T. Neary Purinergic signaling induces thrombospondin-1 expression in astrocytes Proc. Natl. Acad. Sci. U. S. A. 103 2006 9321 9326
251. C.A. Trujillo, T.T. Schwindt, A.H. Martins, J.M. Alves, L.E. Mello, and H. Ulrich Novel perspectives of neural stem cell differentiation: from neurotransmitters to therapeutics Cytom. A 75 2009 38 53
252. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 424 2003 778 783
253. J. Ulas, L.C. Brunner, L. Nguyen, and C.W. Cotman Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study Neuroscience 52 1993 843 854
254. H. Ulrich, M.P. Abbracchio, and G. Burnstock Extrinsic purinergic regulation of neural stem/progenitor cells: implications for CNS development and repair Stem Cell. Revs Rep. 8 2012 755 767
255. D. Vacirca, C. Barbati, B. Scazzocchio, R. Masella, G. Rosano, W. Malorni, and E. Ortona Anti-ATP synthase autoantibodies from patients with Alzheimer's disease reduce extracellular HDL level J. Alzheimers. Dis. 26 2011 441 445
256. D. Vacirca, F. Delunardo, P. Matarrese, T. Colasanti, P. Margutti, A. Siracusano, S. Pontecorvo, A. Capozzi, M. Sorice, A. Francia, W. Malorni, and E. Ortona Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease Neurobiol. Aging 33 2012 753 766
257. 2A receptor signaling in striatal cells expressing mutant huntingtin FASEB J. 15 2001 1245 1247
258. 2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages Neurobiol. Dis. 27 2007 36 43
259. R. Varma, Y. Chai, J. Troncoso, J. Gu, H. Xing, S.S. Stojilkovic, M.P. Mattson, and N.J. Haughey Amyloid-β induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity Neuromolecular Med. 11 2009 63 75
260. C. Verderio, and M. Matteoli ATP in neuron-glia bidirectional signalling Brain Res. Rev. 66 2011 106 114
261. A. Verkhratsky, O.A. Krishtal, and G. Burnstock Purinoceptors in neuroglia Mol. Neurobiol. 39 2009 190 208
262. 2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b Neurobiol. Dis. 69 2014 206 214
263. 2A adenosine receptors that are antiinflammatory when stimulated Eur. J. Immunol. 43 2013 2206 2216
264. M.T. Viscomi, F. Florenzano, D. Conversi, G. Bernardi, and M. Molinari Axotomy dependent purinergic and nitrergic co-expression Neuroscience 123 2004 393 404
265. C. Volonté, S. Amadio, F. Cavaliere, N. D'Ambrosi, F. Vacca, and G. Bernardi Extracellular ATP and neurodegeneration Curr. Drug Targets CNS. Neurol. Disord. 2 2003 403 412
266. C. Volonté, and G. Burnstock Editorial: pharmacology and therapeutic activity of purinergic drugs for disorders of the nervous system CNS Neurol. Disorders-Drug Targets 11 2012 649 651
267. D.K. Von Lubitz, R.C. Lin, P. Popik, M.F. Carter, and K.A. Jacobson Adenosine A3 receptor stimulation and cerebral ischemia Eur. J. Pharmacol. 263 1994 59 67
268. D.K. Von Lubitz, R.C. Lin, and K.A. Jacobson Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist Eur. J. Pharmacol. 287 1995 295 302
269. M.J. Wall, and N. Dale Auto-inhibition of rat parallel fibre-Purkinje cell synapses by activity-dependent adenosine release J. Physiol. 581 2007 553 565
270. --dependent mechanism Glia 37 2002 8 18
271. L.Y. Wang, W.Q. Cai, P.H. Chen, Q.Y. Deng, and C.M. Zhao Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia Glia 57 2009 307 319
272. 7 receptor inhibition improves recovery after spinal cord injury Nat. Med. 10 2004 821 827
273. Y. Wang, C.F. Chang, M. Morales, Y.H. Chiang, B.K. Harvey, T.P. Su, L.I. Tsao, S. Chen, and C. Thiemermann Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain J. Neurosci. 23 2003 7958 7965
274. S. Watanabe, Y. Yoshimi, and M. Ikekita Neuroprotective effect of adenine on purkinje cell survival in rat cerebellar primary cultures J. Neurosci. Res. 74 2003 754 759
275. L.T. Watts, R. Lloyd, R.J. Garling, and T. Duong Stroke neuroprotection: targeting mitochondria Brain Sci. 3 2013 540 560
276. M. Williams Mammalian central adenosine receptors A. Lajtha, Handbook of Neurochemistry 1984 Plenum Publishing Corporation New York 1 25
277. R.L. Williams-Karnesky, and M.P. Stenzel-Poore Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant Curr. Neuropharmacol. 7 2009 217 227
278. 7 receptors in cerebrocortical cell cultures after in vitro ischemia J. Neurochem. 95 2005 1421 1437
279. R.J. Wurtman, M. Cansev, and I.H. Ulus Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides J. Nutr. Health Aging 13 2009 189 197
280. Z. Xiang, M. Chen, J. Ping, P.M. Dunn, J. Lv, B. Jiao, and G. Burnstock Microglial morphology and its transformation after challenge by extracellular ATP in vitro J. Neurosci. Res. 83 2006 91 101
281. 2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents Prostagl. Leukot. Essent. Fat. Acids 69 2003 437 448
282. P. Xu, K.M. Rosen, K. Hedstrom, O. Rey, S. Guha, C. Hart, and G. Corfas Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway Glia 61 2013 1029 1040
283. G.G. Yegutkin Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities Crit. Rev. Biochem. Mol. Biol. 49 2014 473 497
284. Y. Yiangou, P. Facer, P. Durrenberger, I.P. Chessell, A. Naylor, C. Bountra, R.R. Banati, and P. Anand COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurol. 6 2006 12
285. Y. Zhang, P. Deng, Y. Li, and Z.C. Xu Enhancement of excitatory synaptic transmission in spiny neurons after transient forebrain ischemia J. Neurophysiol. 95 2006 1537 1544
286. 2A receptor antagonists for the treatment of Parkinson's disease ACS Chem. Neurosci. 5 2014 674 682
287. H. Zimmermann Signalling via ATP in the nervous system Trends Neurosci. 17 1994 420 426
288. H. Zimmermann Extracellular metabolism of ATP and other nucleotides Naunyn Schmiedeb. Arch. Pharmacol. 362 2000 299 309
289. H. Zimmermann Nucleotide signaling in nervous system development Pflugers Arch. 452 2006 573 588
290. C. Zona, C. Marchetti, C. Volontè, N.B. Mercuri, and G. Bernardi Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons Brain Res. 882 2000 26 35